ROTATION MEDICAL, INC. ARTHRO BIOINDCTIVE 1 MED; MESH, SURGICAL, COLLAGEN, ORTHOPAEDICS, REINFORCEMENT OF TENDON
|
Back to Search Results |
|
Model Number 2169-2 |
Device Problem
Insufficient Information (3190)
|
Patient Problem
Injury (2348)
|
Event Type
Injury
|
Event Description
|
It was reported that, after a surgery in which a regeneten bioinductive implant was used over a repair made to treat a musculotendinous junction tear of the infraspinatus, the patient had objective stiffness early in the post operative course, starting at 6 weeks and which persisted throughout the post operative period.No signs of systemic infection.Imaging 8 9 months out showed subacromial bursistis and a tear in line with tendon fibers.The patient was taken to the or where the subacromial bursa was aspirated, biopsied (with frozen section) and cultured.The subacromial bursa was dense with significant scarring directly over the implant as well as laterally.A washout was performed with vancomycin.The bioinductive implant had integrated into tendon laterally but had lifted medially, which he repaired with suture and performed a side to side repair of the tendon.There was synovitis in the glenohumeral joint, which was largely affected; this was treated intraoperatively with an intra articular steroid injection.The patient was diagnosed with septic bursitis and treated for 6 weeks with vancomycin.Now, several months later, patient has progressed well and has returned to playing cello, though he is reportedly not fully improved.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
|
|
Manufacturer Narrative
|
H3,h6: lot number information is not provided and no additional information received for documentation review.Another complaint related to infection post procedure with scaffold has been observed.The risks associated with complaint are already included in the risk analysis.Also the probability is appropriate.Device labeling was reviewed.All instructions for use and product labels were found to be current, complete and comprehensive.The product used for treatment, was not returned for evaluation and therefore a physical investigation could not be completed.Root cause was undetermined after investigation.Failure mode experienced by the user facility were unable to be confirmed through direct physical investigation.No clinical/medical documentation was provided for the investigation.Without supporting clinical/medical documents a thorough investigation cannot be performed.
|
|
Search Alerts/Recalls
|
|
|